| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |